Tricuspid stenosis echocardiography

Jump to navigation Jump to search

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis echocardiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis echocardiography

CDC on Tricuspid stenosis echocardiography

Tricuspid stenosis echocardiography in the news

Blogs on Tricuspid stenosis echocardiography

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transthoracic echocardiography (TTE) should be performed in a patient with suspected tricuspid stenois to confirm the diagnosis, determine the etiology, and establish the baseline severity.

Echocardiography

2D-Echocardiography

2D-echocardiography is useful to identify the following:

  • Thickening of valve leaflets
  • Calcification
  • restricted mobility
  • " Doming " of the leaflets

Doppler Echocardiography

Doppler echocardiography is useful to assess the severity of tricuspid stenosis through the evaluation of the transvalvular gradient.

  • Using continuous wave doppler across the tricuspid valve in apical-4-chamber view, the peak gradient can be calculated using the modified Bernoulli equation.
  • Pressure half time can be used but is not validated for triscuspid stenosis.
  • Calculation of tricuspid valve area with the continuity equation:[1]

Tricuspid valve area = ( annulus PW Vti * Cross sectional area of the annulus) / valve CW Vti

Assessment of Tricuspid Stenosis Severity with Echocardiography

The main finding of tricuspid stenosis is an elevation in transvalvular velocity. Other TTE findings of tricuspid stenosis include:

  • Valve thickening and calcification
  • Chordal thickening and calcification
  • Decreased mobility
  • Immobility of the leaflets (suggestive of carcinoid syndrome)
  • Tumors or metastatic lesions
  • Valvular vegetations (suggestive of infective endocarditis)

TTE findings that are associated with increased severity of tricuspid stenosis include:

  • Mean pressure gradient >5 mm Hg,
  • Pressure half-time >190 milliseconds
  • Tricuspid valve area < 1.0 cm2
  • Enlargement of the right atrium
  • Enlargement of the inferior vena cava
Severity of tricuspid stenosis
Severity mild moderate severe
Tricuspid valve area - - <1
Mean Pressure Gradient <4 4-7 >7

Differential Diagnosis of a Tricuspid Mass Causing Obstruction

  • Right atrial tumor
  • Right atrial ball valve thrombus
  • Large vegetations

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[2]

Class I
"1. TTE is indicated in patients with TS to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease. (Level of Evidence: C)"

References

  1. Fawzy ME, Mercer EN, Dunn B, al-Amri M, Andaya W (1989). "Doppler echocardiography in the evaluation of tricuspid stenosis". Eur Heart J. 10 (11): 985–90. PMID 2591399.
  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH

Template:WS